The Role of Focal Therapy in the Management of Localised Prostate Cancer: A Systematic Review

[1]  Jun Qi,et al.  Prostate cancer detection with real-time elastography using a bi-plane transducer: comparison with step section radical prostatectomy pathology , 2014, World Journal of Urology.

[2]  A. Larcher,et al.  Complications and quality of life after template-assisted transperineal prostate biopsy in patients eligible for focal therapy. , 2013, Urology.

[3]  M. Lucia,et al.  Clinical‐Pathologic Correlation Between Transperineal Mapping Biopsies of the Prostate and Three‐Dimensional Reconstruction of Prostatectomy Specimens , 2013, The Prostate.

[4]  P. Validire,et al.  Morbidity of focal therapy in the treatment of localized prostate cancer. , 2013, European urology.

[5]  B. Vainer,et al.  Is it possible to predict low‐volume and insignificant prostate cancer by core needle biopsies? , 2013, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[6]  M. Wirth,et al.  Re: Vincenzo Ficarra, Giacomo Novara, Raymond C. Rosen, et al. systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy. Eur Urol 2012;62:405-17. , 2013, European urology.

[7]  Carlo Catalano,et al.  Real-time magnetic resonance-guided high-intensity focused ultrasound focal therapy for localised prostate cancer: preliminary experience. , 2013, European urology.

[8]  J. Stanford,et al.  Long-term functional outcomes after treatment for localized prostate cancer. , 2013, The New England journal of medicine.

[9]  M. Srougi,et al.  Are we able to correctly identify prostate cancer patients who could be adequately treated by focal therapy? , 2012, Urologic oncology.

[10]  P. Choyke,et al.  Progress in prostate cancer imaging. , 2012, Urologic oncology.

[11]  A. D'Amico,et al.  Updated results of magnetic resonance imaging guided partial prostate brachytherapy for favorable risk prostate cancer: implications for focal therapy. , 2012, The Journal of urology.

[12]  Rajiv Chopra,et al.  MR imaging-controlled transurethral ultrasound therapy for conformal treatment of prostate tissue: initial feasibility in humans. , 2012, Radiology.

[13]  H. Ahmed,et al.  Focal salvage therapy for localized prostate cancer recurrence after external beam radiotherapy , 2012, Cancer.

[14]  H. G. van der Poel,et al.  Systematic review and meta-analysis of studies reporting potency rates after robot-assisted radical prostatectomy. , 2012, European urology.

[15]  T. van der Kwast.  The trade-off between sensitivity and specificity of clinical protocols for identification of insignificant prostate cancer. , 2012, European urology.

[16]  J. Eastham,et al.  Systematic review and meta-analysis of perioperative outcomes and complications after robot-assisted radical prostatectomy. , 2012, European urology.

[17]  R. Sutherland,et al.  Location and pathological characteristics of cancers in radical prostatectomy specimens identified by transperineal biopsy compared to transrectal biopsy. , 2012, The Journal of urology.

[18]  H. G. van der Poel,et al.  Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy. , 2012, European urology.

[19]  Yipeng Hu,et al.  A biopsy simulation study to assess the accuracy of several transrectal ultrasonography (TRUS)‐biopsy strategies compared with template prostate mapping biopsies in patients who have undergone radical prostatectomy , 2012, BJU international.

[20]  Nikolai Hungr,et al.  Development of a Novel Robot for Transperineal Needle Based Interventions: Focal Therapy, Brachytherapy and Prostate Biopsies , 2012, The Journal of urology.

[21]  A. Ouzzane,et al.  Quantitative tissue analyses of prostate cancer foci in an unselected cystoprostatectomy series , 2012, BJU international.

[22]  S. Hazell,et al.  Anatomically versus biologically unifocal prostate cancer: a pathological evaluation in the context of focal therapy , 2012, Therapeutic advances in urology.

[23]  C. Magi-Galluzzi,et al.  Discrepancy in prostate cancer localization between biopsy and prostatectomy specimens in patients with unilateral positive biopsy: Implications for focal therapy , 2012, The Prostate.

[24]  Timothy J Wilt,et al.  Radical prostatectomy versus observation for localized prostate cancer. , 2012, The New England journal of medicine.

[25]  U. Capitanio,et al.  Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound‐guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy , 2012, BJU international.

[26]  Osamu Ukimura,et al.  Focal cryotherapy for clinically unilateral, low-intermediate risk prostate cancer in 73 men with a median follow-up of 3.7 years. , 2012, European urology.

[27]  Johan Braeckman,et al.  Detection, localisation and characterisation of prostate cancer by Prostate HistoScanning™ , 2012, BJU international.

[28]  Martijn Smeenge,et al.  Current status of transrectal ultrasound techniques in prostate cancer , 2012, Current opinion in urology.

[29]  P. Carroll,et al.  Transrectal ultrasonography‐guided biopsy does not reliably identify dominant cancer location in men with low‐risk prostate cancer , 2012, BJU international.

[30]  H. Ahmed,et al.  Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study , 2012, The Lancet. Oncology.

[31]  John Kurhanewicz,et al.  Transatlantic Consensus Group on active surveillance and focal therapy for prostate cancer , 2012, BJU international.

[32]  P. Brenner,et al.  Accuracy of primary systematic template guided transperineal biopsy of the prostate for locating prostate cancer: a comparison with radical prostatectomy specimens. , 2012, The Journal of urology.

[33]  J. Ward,et al.  Focal cryotherapy for localized prostate cancer: a report from the national Cryo On‐Line Database (COLD) Registry , 2012, BJU international.

[34]  Ronald C. Chen,et al.  Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer. , 2012, JAMA.

[35]  Benjamin J. Raphael,et al.  The Mutational Landscape of Lethal Castrate Resistant Prostate Cancer , 2012, Nature.

[36]  Mark Emberton,et al.  Report of a consensus meeting on focal low dose rate brachytherapy for prostate cancer , 2012, BJU international.

[37]  C. Stief,et al.  Animal models in urinary diversion , 2012, BJU international.

[38]  P. Corso,et al.  NIH State-of-the-Science Conference Statement: Role of active surveillance in the management of men with localized prostate cancer. , 2011, NIH consensus and state-of-the-science statements.

[39]  X. Rébillard,et al.  Correlation of prostate‐specific antigen nadir and biochemical failure after high‐intensity focused ultrasound of localized prostate cancer based on the Stuttgart failure criteria – analysis from the @‐Registry , 2011, BJU international.

[40]  D. Bostwick,et al.  Understanding the pathological features of focality, grade and tumour volume of early‐stage prostate cancer as a foundation for parenchyma‐sparing prostate cancer therapies: active surveillance and focal targeted therapy , 2011, BJU international.

[41]  J. Oxley,et al.  Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT study , 2011, British Journal of Cancer.

[42]  Yipeng Hu,et al.  Characterizing clinically significant prostate cancer using template prostate mapping biopsy. , 2011, The Journal of urology.

[43]  E. Crawford,et al.  The role of 3-dimensional mapping biopsy in decision making for treatment of apparent early stage prostate cancer. , 2011, The Journal of urology.

[44]  Liang Cheng,et al.  Pathological characterization of unifocal prostate cancers in whole‐mount radical prostatectomy specimens , 2011, BJU international.

[45]  H. Ahmed,et al.  Focal therapy for localized prostate cancer: a phase I/II trial. , 2011, The Journal of urology.

[46]  E. Barret,et al.  Focal therapy with high-intensity focused ultrasound for prostate cancer in the elderly. A feasibility study with 10 years follow-up. , 2011, International braz j urol : official journal of the Brazilian Society of Urology.

[47]  J. Madden,et al.  Can the conventional sextant prostate biopsy accurately predict unilateral prostate cancer in low-risk, localized, prostate cancer? , 2011, Urologic oncology.

[48]  P. McCulloch.  The IDEAL recommendations and urological innovation , 2011, World Journal of Urology.

[49]  Joseph A. Graversen,et al.  Active Surveillance of Renal Cortical Neoplasms: A Contemporary Review , 2011, Postgraduate medicine.

[50]  Alex Freeman,et al.  The index lesion and focal therapy: an analysis of the pathological characteristics of prostate cancer , 2010, BJU international.

[51]  Yuzhuo Wang,et al.  Development of metastatic and non‐metastatic tumor lines from a patient's prostate cancer specimen—identification of a small subpopulation with metastatic potential in the primary tumor , 2010, The Prostate.

[52]  Nathan Lawrentschuk,et al.  Focal therapy in prostate cancer: modalities, findings and future considerations , 2010, Nature Reviews Urology.

[53]  A. Katz,et al.  An Evaluation of Patient Selection Criteria on Predicting Progression-Free Survival After Primary Focal Unilateral Nerve-Sparing Cryoablation for Prostate Cancer: Recommendations for Follow Up , 2010, Cancer journal.

[54]  P. Scardino,et al.  Focal therapy for prostate cancer: possibilities and limitations. , 2010, European urology.

[55]  R. Weersink,et al.  Real-time magnetic resonance imaging-guided focal laser therapy in patients with low-risk prostate cancer. , 2010, European urology.

[56]  T. H. van der Kwast,et al.  Focal laser ablation for prostate cancer followed by radical prostatectomy: validation of focal therapy and imaging accuracy. , 2010, European urology.

[57]  M Emberton,et al.  Focal therapy in prostate cancer-report from a consensus panel. , 2010, Journal of endourology.

[58]  F. Algaba,et al.  Impact of prostate cancer multifocality on its biology and treatment. , 2010, Journal of endourology.

[59]  V. Mouraviev,et al.  Predicting unilateral prostate cancer on routine diagnostic biopsy: sextant vs extended , 2010, BJU international.

[60]  M. Pike,et al.  National Institutes of Health State-of-the-Science Conference statement: Diagnosis and Management of Ductal Carcinoma In Situ September 22-24, 2009. , 2010, Journal of the National Cancer Institute.

[61]  Hashim Uddin Ahmed,et al.  The index lesion and the origin of prostate cancer. , 2009, The New England journal of medicine.

[62]  Liang Cheng,et al.  Pathology of prostate cancer and focal therapy ('male lumpectomy'). , 2009, Anticancer research.

[63]  Xavier Leroy,et al.  Dynamic contrast-enhanced-magnetic resonance imaging evaluation of intraprostatic prostate cancer: correlation with radical prostatectomy specimens. , 2009, Urology.

[64]  A Fenster,et al.  Image guided photothermal focal therapy for localized prostate cancer: phase I trial. , 2009, The Journal of urology.

[65]  H. Ahmed,et al.  MP-16.13: Vascular-Targeted Photodynamic Therapy Using WST11 in Patients with Localized Prostate Cancer , 2009 .

[66]  David W. Taggart,et al.  No surgical innovation without evaluation: the IDEAL recommendations , 2009, The Lancet.

[67]  D. Bostwick,et al.  Three-dimensional prostate mapping biopsy has a potentially significant impact on prostate cancer management. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[68]  P. Troncoso,et al.  Cancer ablation with regional templates applied to prostatectomy specimens from men who were eligible for focal therapy , 2009, BJU international.

[69]  J. Moul,et al.  Patient selection for hemiablative focal therapy of prostate cancer , 2009, Cancer.

[70]  Jun Luo,et al.  Copy Number Analysis Indicates Monoclonal Origin of Lethal Metastatic Prostate Cancer , 2009, Nature Medicine.

[71]  J. Chapelon,et al.  854 FOCAL THERAPY OF PROSTATE CANCER (PCA) WITH HIFU: INFLUENCE ON ERECTILE DYSFUNCTION (ED) , 2009 .

[72]  K. Shinohara,et al.  Partial salvage cryoablation of the prostate for recurrent prostate cancer after radiotherapy failure. , 2008, Urology.

[73]  J. Moul,et al.  Pathologic stage T2a and T2b prostate cancer in the recent prostate‐specific antigen era: Implications for unilateral ablative therapy , 2008, The Prostate.

[74]  S. Horie,et al.  Focal therapy with high-intensity-focused ultrasound in the treatment of localized prostate cancer. , 2008, Japanese journal of clinical oncology.

[75]  E. Klein,et al.  Localized Prostate Cancer , 2007 .

[76]  G. Onik,et al.  "Male lumpectomy": focal therapy for prostate cancer using cryoablation. , 2007, Urology.

[77]  Oliver Sartor,et al.  Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities. , 2007, The Journal of urology.

[78]  J. Rewcastle,et al.  Focal cryosurgery followed by penile rehabilitation as primary treatment for localized prostate cancer: initial results. , 2007, Urology.

[79]  D. Bostwick,et al.  Group consensus reports from the Consensus Conference on Focal Treatment of Prostatic Carcinoma, Celebration, Florida, February 24, 2006. , 2007, Urology.

[80]  Hashim Uddin Ahmed,et al.  Will focal therapy become a standard of care for men with localized prostate cancer? , 2007, Nature Clinical Practice Oncology.

[81]  Ming-Hui Chen,et al.  Magnetic resonance image‐guided salvage brachytherapy after radiation in select men who initially presented with favorable‐risk prostate cancer , 2007, Cancer.

[82]  J. Moul,et al.  Prostate cancer laterality as a rationale of focal ablative therapy for the treatment of clinically localized prostate cancer , 2007, Cancer.

[83]  J. Madden,et al.  Analysis of Laterality and Percentage of Tumor Involvement in 1386 Prostatectomized Specimens for Selection of Unilateral Focal Cryotherapy , 2007, Technology in cancer research & treatment.

[84]  A. Villers,et al.  Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings. , 2006, The Journal of urology.

[85]  J. Rewcastle,et al.  Focal prostate cryoablation: initial results show cancer control and potency preservation. , 2006, Journal of endourology.

[86]  Paul Schellhammer,et al.  Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. , 2006, International journal of radiation oncology, biology, physics.

[87]  M Emberton,et al.  Photodynamic therapy using meso tetra hydroxy phenyl chlorin (mTHPC) in early prostate cancer , 2006, Lasers in surgery and medicine.

[88]  Liang Cheng,et al.  Papillary urothelial neoplasm of low malignant potential: evolving terminology and concepts. , 2006, The Journal of urology.

[89]  S. Shariat,et al.  Pilot study of radiofrequency interstitial tumor ablation (RITA) for the treatment of radio‐recurrent prostate cancer , 2005, The Prostate.

[90]  Jonathan Ophir,et al.  Visualisation of HIFU lesions using elastography of the human prostate in vivo: preliminary results. , 2003, Ultrasound in medicine & biology.

[91]  T. Stamey,et al.  Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens. , 2002, Urology.

[92]  J. J. de la Rosette,et al.  Transrectal high-intensity focused ultrasound using the Ablatherm device in the treatment of localized prostate carcinoma. , 1999, Urology.

[93]  A. Zlotta,et al.  Percutaneous transperineal radiofrequency ablation of prostate tumour: safety, feasibility and pathological effects on human prostate cancer. , 1998, British journal of urology.

[94]  M. Marberger,et al.  Effect of high-intensity focused ultrasound on human prostate cancer in vivo. , 1995, Cancer research.

[95]  P. Humphrey.  Complete Histologic Serial Sectioning of a Prostate Gland with Adenocarcinoma , 1993, The American journal of surgical pathology.

[96]  A S Whittemore,et al.  Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer , 1993, Cancer.

[97]  J. Moul,et al.  Biopsy accuracy in identifying unilateral prostate cancer depends on prostate weight. , 2012, Urologic oncology.

[98]  T. H. van der Kwast,et al.  A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial. , 2011, The Journal of urology.

[99]  S. Asa,et al.  Controversies in papillary microcarcinoma of the thyroid , 2003, Endocrine pathology.